600666.SH
奥瑞德
SSE · Healthcare · Drug Manufacturers - General · CN
CNY 3.38
−2.87%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
32.0x
Market Cap
CNY 9.30B
MomentumView details →
1D Return
−2.87%
YTD Return
+4.17%
RSI (14)
44.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
32.0x
Market Cap
CNY 9.30B
RSI (14)
44.6
MomentumView details →
1D Return
−2.87%
YTD Return
+4.17%
Similar companies
Latest newsMore news →
A court-ordered auction of shares held by a 5%+ shareholder of Aorui (Oriental) was completed, with Wei Wei and Wang Feiyan acquiring 60.8 million restricted shares, reducing the shareholder's stake to 3.98%.19d agoTaiji Group's controlling subsidiary Southwest Pharmaceutical received a drug registration certificate from the National Medical Products Administration for butorphanol tartrate injection, in specifications of 1ml:1mg and 2ml:4mg, for the treatment of cancer pain and postoperative pain.26d ago